期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
The role of drug utilization evaluation in medical sciences
1
作者 Ruby Gangwar Arvind Kumar +2 位作者 Abrar Ahmed Zargar Amit Sharma Ranjeet Kumar 《Global Health Journal》 2023年第1期3-8,共6页
Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in ... Background:Drug utilization evaluation(DUE)is defined by the World Health Organization(WHO)and focuses on the medical,social,and economic consequences of pharmaceutical marketing,distribution,prescribing,and usage in society.The WHO recommends a physician to every 1000 people.According to the recent data from the Health Ministry in 2019,in which 1.16 million doctors are of active population with just 80%,or 0.9 million,practicing.As a result,a ratio of 0.68 doctors for every 1000 people,which is much below as per the WHO reports.This article describes history,types,WHO guidelines,need and purpose of DUE.Objective:The main aim of this paper is to provide information about the rational use of medication in outpa­tient and inpatient department with special emphasis of DUEs.It also provides awareness directly to healthcare professionals,researchers,academicians,pharmacist and nurses to reduce the irrationality of medicines.Methods:The method used to compile this review information gathered from websites,Google scholar,PubMed,Research gate,and studies published on DUE from July 20 to Oct 22 were included as source of information.Results:We studied more than 35 published study on DUE,that reveals most of the physicians prescribed branded drugs not generic drugs,but WHO prescribing indicator allows to prescribe generic drugs in the hospital pharmacy to maintain better inventory control.It may also help to prevent pharmacist misunderstanding during dispensing.Conclusion:The use of generic prescription names avoids the possibility of medication product duplication and lowers patient costs.It is important to remember that incorrect medication prescriptions have impact on both patients and their family members.WHO indicators identify irrational prescribing behaviours to make therapy more rational and cost-effective. 展开更多
关键词 anatomical therapeutic chemical classification Drug utilization evaluation Prescribing indicators Pregnancy risk classification Rational use of the drug
下载PDF
基于药品分类的活性药物成分职业健康风险识别探索
2
作者 张霞 谢印 +4 位作者 鲍萍萍 唐颖 陈健 李静 朱素蓉 《中国卫生资源》 北大核心 2022年第5期607-612,共6页
目的 基于药品分类视角,分析药品分类编码所体现的疾病领域和作用机制信息,探索基于药品分类系统实现活性药物成分职业健康风险初步识别的可行性。方法 梳理《中华人民共和国药典(二部)》作为候选药品清单,应用解剖学、治疗学、化学(ATC... 目的 基于药品分类视角,分析药品分类编码所体现的疾病领域和作用机制信息,探索基于药品分类系统实现活性药物成分职业健康风险初步识别的可行性。方法 梳理《中华人民共和国药典(二部)》作为候选药品清单,应用解剖学、治疗学、化学(ATC)分类系统对美国国家职业安全卫生研究所(NIOSH)危害药品清单和候选药品清单进行编码,分析危害药品的疾病领域和作用机制。结果 NIOSH危害药品清单以L类抗肿瘤药和免疫功能调节药为主(占65%),覆盖我国药典候选药品中L类药品的93%,涉及9种作用机制。非L类药品分布较分散,以G类生殖泌尿系统和性激素、N类神经系统、C类心血管系统、J类系统用抗感染药、H类非性激素和胰岛素类的激素类系统用药为主。结论 基于疾病领域和作用机制识别高风险药品是对常规职业健康风险评估思路的拓展,是一种易于在作业场所实施的分类管理思路。在开展活性药物成分职业健康风险管控时,建议重点关注抗肿瘤药和免疫功能调节药。 展开更多
关键词 职业健康occupational health 风险识别risk identification 解剖学、治疗学、化学分类anatomical therapeutic chemical classification ATC 疾病领域disease area 作用机制mechanism of action
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部